This website is no longer updated

The Swiss National COVID-19 Science Task Force was dissolved on 31 March 2022.

It has been replaced by the Scientific Advisory Panel to ensure that the cantons and the Confederation can continue to benefit from scientific expertise in the context of the SARS-CoV-2 pandemic.

This website is therefore no longer updated, but its content remains accessible as an archive.

25. March 2021

– Policy Brief –

The economic benefits of an accelerated vaccination campaign

Download Policy Brief PDF

Text in German

See also the Policy Briefs Covid-19 Vaccines: Process to determine priority and allocation & National and International Responsibilities for Access , Requirements and Scope of Digital Certificates

Type of document: Policy Brief

Date of response: 15/03/2021

Experts involved: Economics, with input from Manuel Battegay

Contact persons: Marius Brülhart, Aymo Brunetti, Jan-Egbert Sturm